- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00230139
SPECT/CT in Endocrine and Neuroendocrine Tumors
The Added Value of SPECT/CT in the Evaluation of Endocrine and Neuroendocrine Tumors
The value of fusion of functional and anatomical data has been described using several fusion techniques for various nuclear medicine procedures and morphologic imaging modalities (SPECT-CT, SPECT-MRI, Coincidence-CT). We hypothesize that NM -CT data has advantages over the data obtained using separately performed NM study and conventional anatomic imaging as CT. We hypothesize that more accurate localization of the radio-isotope activity on NM images will improve diagnostic accuracy and will have an impact on patient management:
Improved accuracy of NM study will improve tumor localization, the evaluation of the extent of disease and the post therapy follow up.
It will direct other diagnostic procedures to lesions otherwise undetected, or exclude the need for more invasive procedures. It can also guide invasive procedures and radiation-therapy planning, thus improving therapy results and avoiding unnecessary treatment-related side effects.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The value of fusion of functional and anatomical data has been described using several fusion techniques for various nuclear medicine procedures and morphologic imaging modalities (SPECT-CT, SPECT-MRI, Coincidence-CT). We hypothesize that NM -CT data has advantages over the data obtained using separately performed NM study and conventional anatomic imaging as CT. We hypothesize that more accurate localization of the radio-isotope activity on NM images will improve diagnostic accuracy and will have an impact on patient management:
Improved accuracy of NM study will improve tumor localization, the evaluation of the extent of disease and the post therapy follow up.
It will direct other diagnostic procedures to lesions otherwise undetected, or exclude the need for more invasive procedures. It can also guide invasive procedures and radiation-therapy planning, thus improving therapy results and avoiding unnecessary treatment-related side effects.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Haifa, Israel
- Rambam Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient referred for NM scintigraphy to assess the presence of endocrine or neuroendocrine tumors.
- Patient signed informed consent
Exclusion Criteria:
- The study will not be performed in pregnant or lactating women.
- Patient will not be able or willing to tolerate the scan until its completion.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
The impact of imaging modality on patient management
|
Secondary Outcome Measures
Outcome Measure |
---|
The impact of imaging modality on patient management
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Zohar Keidar, MD,PhD, Rambam Health Care Campus
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- endocrineCTIL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endocrine and Neuroendocrine Tumors
-
Novartis PharmaceuticalsCompletedCarcinoma | Neuroendocrine | Advanced and Metastatic Silent Neuro-Endocrine Tumors | Non Functioning Neuroendocrine Tumors (NETs) | Non Syndromic Neuroendocrine Tumors | Carcinoids | Non FunctioningSweden, Italy, Germany, United Kingdom, Spain, France, Netherlands, Poland
-
Shanghai Jiao Tong University School of MedicineRecruitingMedullary Thyroid Cancer | Pancreatic Neuroendocrine Tumor | Adrenal Cortical Carcinoma | Thymic Neuroendocrine CarcinomaChina
-
Hospices Civils de LyonRecruiting
-
Assistance Publique - Hôpitaux de ParisUnknownFecal Microbiota | Digestive Neuroendocrine Tumor | Bacterial Signature
-
Memorial Sloan Kettering Cancer CenterCompletedPancreatic Neuroendocrine CancerUnited States
-
Grupo Espanol de Tumores NeuroendocrinosCompleted
-
Jewish General HospitalCompleted
-
University Hospital, BordeauxCompletedNeuroendocrine TumorsFrance
-
Medical University of ViennaNot yet recruitingPancreatic Neuroendocrine Tumors in MEN1
-
National Cancer Institute (NCI)CompletedRefractory Pancreatic Neuroendocrine Carcinoma | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2United States
Clinical Trials on SPECT/CT
-
Yale UniversityUniversity of Illinois at Urbana-ChampaignRecruitingDiabetes Mellitus | Peripheral Arterial DiseaseUnited States
-
Rambam Health Care CampusCompleted
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedBreast Cancer FemaleRussian Federation
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaTerminated
-
BAMF HealthRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Central Hospital, Nancy, FranceCompleted
-
Martini Hospital GroningenRecruitingOsteoarthritis | Osteoarthritis AnkleNetherlands
-
Mayo ClinicRecruitingFocus of Study is Comparison of 2 Types of Gamma CamerasUnited States
-
University of California, San FranciscoCompletedFeasibility of Using SPECT/CT Imaging to Map Lymphatic Drainage Patterns in Prostate Cancer PatientsProstate CancerUnited States
-
Lille Catholic UniversityRecruitingHeart Diseases | Brain Diseases | Kidney Diseases | Thyroid Diseases | Bone DiseasesFrance